MedPath

PanGenetics UK Limited

Ownership
Private
Employees
-
Market Cap
-
Website

Single Dose PG102 in Patients With Active Psoriatic Arthritis

Phase 1
Terminated
Conditions
Arthritis, Psoriatic
Interventions
Drug: Placebo comparator
First Posted Date
2008-11-07
Last Posted Date
2010-10-26
Lead Sponsor
PanGenetics UK Limited
Target Recruit Count
17
Registration Number
NCT00787137
Locations
🇷🇸

Professor Nemanja Damjanov, Belgrade, Serbia

© Copyright 2025. All Rights Reserved by MedPath